Company Number: 14603065

Analysis Date: 2025-07-20 15:18 UTC

1. Credit Opinion: DECLINE. Eulophia Ltd is a newly incorporated micro-entity with minimal financial data and negligible financial substance. The balance sheet shows current assets of £1 with no liabilities, indicating no meaningful trading activity or cash flow generation. The company’s sole financial figure of £1 in net assets and shareholders’ funds is insufficient to support any credit exposure. Additionally, there is no evidence of revenue, profitability, or working capital to service debt or commercial obligations. The company’s short operating history and lack of financial performance metrics present a high risk for lending or extending credit.

2. Financial Strength: The financial strength is extremely weak. The company reports only £1 in current assets, no liabilities, and net assets of £1. Being a micro-entity, it has minimal reporting requirements, but the absence of any substantive asset base or financial reserves signals no financial buffer. No fixed assets or cash balances are reported, and no profit or loss figures are available. The company’s equity is nominal, reflecting its recent incorporation and lack of trading history. This position provides no comfort regarding its financial resilience or ability to absorb shocks.

3. Cash Flow Assessment: Cash flow assessment is not feasible given the data. The reported current assets of £1 likely represent nominal cash or a similar token value, with no indication of revenue generation or working capital management. There are no creditors, but also no debtors or stock to suggest operating activity. Without cash flow from operations or access to liquid assets, the company cannot currently meet any debt service obligations or unexpected expenses.

4. Monitoring Points:

• Obtain updated financial statements once trading commences and revenues materialize.
• Monitor cash flow statements for evidence of positive operating cash flow.
• Track changes in net current assets and net assets to detect growth or deterioration.
• Review director management and business plans to assess strategy and creditworthiness.
• Watch for any overdue filings or changes in company status that may indicate distress.